Moreover, LOXL2 promotes the activation of FAK/SRC and is involved in regulation of expression of CDH1, Snail, and L1CAM, all of which are related to EMT and invasiveness of pancreatic tumor cells. Here, LOXL2 is linked to pancreatic neoplasm.